Zhou HH - Search Results

1

Genetic analysis of the S-mephenytoin polymorphism in a Chinese population.

de Morais SM, Goldstein JA, Xie HG, Huang SL, Lu YQ, Xia H, Xiao ZS, Ile N, Zhou HH. de Morais SM, et al. Among authors: zhou hh. Clin Pharmacol Ther. 1995 Oct;58(4):404-11. doi: 10.1016/0009-9236(95)90053-5. Clin Pharmacol Ther. 1995. PMID: 7586932

2

Induction of polymorphic 4'-hydroxylation of S-mephenytoin by rifampicin.

Zhou HH, Anthony LB, Wood AJ, Wilkinson GR. Zhou HH, et al. Br J Clin Pharmacol. 1990 Sep;30(3):471-5. doi: 10.1111/j.1365-2125.1990.tb03799.x. Br J Clin Pharmacol. 1990. PMID: 2223426 Free PMC article.

3

Metoprolol and mephenytoin oxidation polymorphisms in Far Eastern Oriental subjects: Japanese versus mainland Chinese.

Horai Y, Nakano M, Ishizaki T, Ishikawa K, Zhou HH, Zhou BI, Liao CL, Zhang LM. Horai Y, et al. Among authors: zhou bi, zhou hh. Clin Pharmacol Ther. 1989 Aug;46(2):198-207. doi: 10.1038/clpt.1989.126. Clin Pharmacol Ther. 1989. PMID: 2758729

4

High-performance liquid chromatographic determination of urinary 4'-hydroxymephenytoin, a metabolic marker for the hepatic enzyme CYP2C19, in humans.

Xie HG, Huang SL, Zhou HH. Xie HG, et al. Among authors: zhou hh. J Chromatogr B Biomed Appl. 1995 Jun 9;668(1):125-31. doi: 10.1016/0378-4347(95)00065-q. J Chromatogr B Biomed Appl. 1995. PMID: 7550968

5

Stereoselective disposition of carvedilol is determined by CYP2D6.

Zhou HH, Wood AJ. Zhou HH, et al. Clin Pharmacol Ther. 1995 May;57(5):518-24. doi: 10.1016/0009-9236(95)90036-5. Clin Pharmacol Ther. 1995. PMID: 7768074

6

Assay of metoprolol and alpha-hydroxymetoprolol in human urine by reversed-phase liquid chromatography with direct-injection.

Xie HG, Zhou HH. Xie HG, et al. Among authors: zhou hh. Zhongguo Yao Li Xue Bao. 1995 Jan;16(1):32-5. Zhongguo Yao Li Xue Bao. 1995. PMID: 7771192 Free article.

7

Genetic polymorphisms of debrisoquine and S-mephenytoin oxidation metabolism in Chinese populations: a meta-analysis.

Xie HG, Xu ZH, Luo X, Huang SL, Zeng FD, Zhou HH. Xie HG, et al. Among authors: zhou hh. Pharmacogenetics. 1996 Jun;6(3):235-8. doi: 10.1097/00008571-199606000-00005. Pharmacogenetics. 1996. PMID: 8807662

8

The elimination of diazepam in Chinese subjects is dependent on the mephenytoin oxidation phenotype.

Wan J, Xia H, He N, Lu YQ, Zhou HH. Wan J, et al. Among authors: zhou hh. Br J Clin Pharmacol. 1996 Oct;42(4):471-4. doi: 10.1046/j.1365-2125.1996.42712.x. Br J Clin Pharmacol. 1996. PMID: 8904619 Free PMC article.

9

In vivo inhibition of CYP2C19 but not CYP2D6 by fluvoxamine.

Xu ZH, Xie HG, Zhou HH. Xu ZH, et al. Among authors: zhou hh. Br J Clin Pharmacol. 1996 Oct;42(4):518-21. doi: 10.1046/j.1365-2125.1996.45319.x. Br J Clin Pharmacol. 1996. PMID: 8904628 Free PMC article.

10

Differences in the incidence of the CYP2C19 polymorphism affecting the S-mephenytoin phenotype in Chinese Han and Bai populations and identification of a new rare CYP2C19 mutant allele.

Xiao ZS, Goldstein JA, Xie HG, Blaisdell J, Wang W, Jiang CH, Yan FX, He N, Huang SL, Xu ZH, Zhou HH. Xiao ZS, et al. Among authors: zhou hh. J Pharmacol Exp Ther. 1997 Apr;281(1):604-9. J Pharmacol Exp Ther. 1997. PMID: 9103550

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

725 results

Search Page

Filters